F de Wolf

1.2k total citations
20 papers, 945 citations indexed

About

F de Wolf is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, F de Wolf has authored 20 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Virology, 12 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in F de Wolf's work include HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (6 papers). F de Wolf is often cited by papers focused on HIV Research and Treatment (16 papers), HIV/AIDS drug development and treatment (11 papers) and HIV/AIDS Research and Interventions (6 papers). F de Wolf collaborates with scholars based in Netherlands, Vietnam and United States. F de Wolf's co-authors include J. van der Noordaa, Jaap Goudsmit, J. M. A. Lange, S. A. Danner, Deborah A. Paul, R A Coutinho, Henk van den Berg, Frank Miedema, Han G. Huisman and Jaap Goudsmit and has published in prestigious journals such as The Lancet, The Journal of Infectious Diseases and Annals of Oncology.

In The Last Decade

F de Wolf

19 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F de Wolf Netherlands 10 759 484 286 234 106 20 945
Theresa Calvelli United States 11 375 0.5× 322 0.7× 211 0.7× 169 0.7× 102 1.0× 31 666
Eva Maria Fenyö Sweden 18 963 1.3× 632 1.3× 389 1.4× 263 1.1× 125 1.2× 26 1.1k
Elly Baan Netherlands 15 768 1.0× 533 1.1× 239 0.8× 142 0.6× 115 1.1× 21 859
Catherine Tamalet France 22 813 1.1× 715 1.5× 204 0.7× 345 1.5× 141 1.3× 49 1.3k
Marie-Anne Rey-Cuillé France 12 650 0.9× 330 0.7× 427 1.5× 306 1.3× 160 1.5× 16 957
P A Broliden Sweden 15 644 0.8× 348 0.7× 369 1.3× 149 0.6× 139 1.3× 16 853
Betty Willems Belgium 17 660 0.9× 494 1.0× 210 0.7× 160 0.7× 103 1.0× 39 776
J Lange Netherlands 15 672 0.9× 623 1.3× 110 0.4× 250 1.1× 59 0.6× 23 910
F Massari United States 4 720 0.9× 456 0.9× 308 1.1× 215 0.9× 66 0.6× 6 829
Gaël Petitjean France 14 775 1.0× 346 0.7× 594 2.1× 287 1.2× 106 1.0× 18 1.1k

Countries citing papers authored by F de Wolf

Since Specialization
Citations

This map shows the geographic impact of F de Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F de Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F de Wolf more than expected).

Fields of papers citing papers by F de Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F de Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F de Wolf. The network helps show where F de Wolf may publish in the future.

Co-authorship network of co-authors of F de Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of F de Wolf. A scholar is included among the top collaborators of F de Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F de Wolf. F de Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
May, Margaret, Caroline Sabin, Geneviève Chêne, et al.. (2015). Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy. Open Access CRIS of the University of Bern.
2.
Sterne, Jonathan A C, Margaret May, Dominique Costagliola, et al.. (2003). 10th Conference on Retroviruses and Opportunistic Infections 2003 Boston, USA. 7 indexed citations
3.
Chêne, Geneviève, Margaret May, Dominique Costagliola, et al.. (2002). Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration. Explore Bristol Research. 5 indexed citations
4.
Jambroes, Mariëlle, Gerrit Jan Weverling, Peter Reiss, et al.. (2001). [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].. PubMed. 145(33). 1591–7. 2 indexed citations
5.
Nieuwkerk, Pythia T., D.M. Burger, Marc van der Valk, et al.. (2001). Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study. University of Groningen research database (University of Groningen / Centre for Information Technology). 161(16). 1962–1968. 7 indexed citations
6.
Kersten, Marie José, et al.. (1998). Treatment of AIDS-related non-Hodgkin’s lymphoma with chemotherapy (CNOP) and r-hu-G-CSF: Clinical outcome and effect on HIV-1 viral load. Annals of Oncology. 9(10). 1135–1138. 12 indexed citations
7.
Baalen, Carel A. van, R. C. Huisman, Michèl R. Klein, et al.. (1997). Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.. Journal of General Virology. 78(8). 1913–1918. 162 indexed citations
8.
9.
Jong, J J de, Suzanne Jurriaans, R A Coutinho, F de Wolf, & Jaap Goudsmit. (1997). [Zidovudine-resistant HIV strains in untreated intravenous drug users and homosexual men in Amsterdam infected in 1996].. PubMed. 141(42). 2030–1. 2 indexed citations
10.
Portegies, Peter, et al.. (1996). Decline of HIV-1 RNA in cerebrospinal fluid during zidovudine treatment.. PubMed. 1(3). 195–195. 2 indexed citations
11.
Hogervorst, Els J. M., Suzanne Jurriaans, F de Wolf, et al.. (1995). Predictors for Non- and Slow Progression in Human Immunodeficiency Virus (HIV) Type 1 Infection: Low Viral RNA Copy Numbers in Serum and Maintenance of High HIV-1 p24-Specific but Not V3-Specific Antibody Levels. The Journal of Infectious Diseases. 171(4). 811–821. 122 indexed citations
12.
Mulder, Jan W., P. H. J. Frissen, Pieta Krijnen, et al.. (1992). Dehydroepiandrosterone as Predictor for Progression to AIDS in Asymptomatic Human Immunodeficiency Virus-Infected Men. The Journal of Infectious Diseases. 165(3). 413–418. 54 indexed citations
13.
Reiss, Peter, F de Wolf, Carla Kuiken, et al.. (1991). Contribution of antibody response to recombinant HIV-1 gene-encoded products nef, rev, tat, and protease in predicting development of AIDS in HIV-1-infected individuals.. PubMed. 4(2). 165–72. 17 indexed citations
14.
Miedema, Frank, Jan Karel M. Eeftinck Schattenkerk, F de Wolf, et al.. (1989). Cellular and humoral immunity in various cohorts of male homosexuals in relation to infection with human immunodeficiency virus.. Data Archiving and Networked Services (DANS). 34(3-4). 132–41. 8 indexed citations
15.
Goudsmit, Jaap, Gabriël Zwart, Margreet Bakker, et al.. (1989). Antibody recognition of amino acid divergence within an HIV-1 neutralization epitope. Research in Virology. 140(5). 419–436. 7 indexed citations
16.
Wolf, F de, Jaap Goudsmit, Jan de Gans, et al.. (1988). EFFECT OF ZIDOVUDINE ON SERUM HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN LEVELS IN SYMPTOM-FREE SUBJECTS. The Lancet. 331(8582). 373–376. 73 indexed citations
17.
Lange, Joep M. A., Jaap Goudsmit, F de Wolf, R A Coutinho, & J. van der Noordaa. (1988). Serological markers in HIV infection.. PubMed. 139(2). 80–3. 12 indexed citations
18.
19.
Coutinho, R A, Jaap Goudsmit, Deborah A. Paul, et al.. (1987). The natural history of HIV infection in homosexual men. Annales de l Institut Pasteur Virologie. 138(1). 67–74. 5 indexed citations
20.
Lange, J. M. A., Deborah A. Paul, Han G. Huisman, et al.. (1986). Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.. BMJ. 293(6560). 1459–1462. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theresa Calvelli Breakdown of academic impact, for papers by Eva Maria Fenyö Breakdown of academic impact, for papers by Elly Baan Breakdown of academic impact, for papers by Catherine Tamalet Breakdown of academic impact, for papers by Marie-Anne Rey-Cuillé Breakdown of academic impact, for papers by P A Broliden Breakdown of academic impact, for papers by Betty Willems Breakdown of academic impact, for papers by J Lange Breakdown of academic impact, for papers by F Massari Breakdown of academic impact, for papers by Gaël Petitjean
Rankless by CCL
2026